Pharvaris (PHVS) Other Working Capital Changes (2021 - 2026)

Pharvaris (PHVS) posted Other Working Capital Changes of -$17982.1 for Q1 2022.

Pharvaris (PHVS) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Pharvaris' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

Quarterly Other Working Capital Changes fell 5.38% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 196.06% YoY) and the FY2025 annual result came in at $2.0 million, up 1436.23% from the prior year.
Other Working Capital Changes was -$17982.1 for Q1 2022 at Pharvaris.
Across five years, Other Working Capital Changes topped out at $5285.8 billion in Q3 2023 and bottomed at -$5287.4 billion in Q2 2023.
A 5-year average of -$95.6 million and a median of $234668.8 in 2025 frame the typical range for Other Working Capital Changes.
Peak annual rise in Other Working Capital Changes reached 1412968002.67% in 2023, while the deepest fall reached 695583948.37% in 2023.
Pharvaris' Other Working Capital Changes stood at -$325334.4 in 2022, then soared by 1512.62% to $4.6 million in 2023, then tumbled by 132.72% to -$1.5 million in 2024, then surged by 115.6% to $234668.8 in 2025, then sank by 711.56% to -$1.4 million in 2026.
Business Quant data shows PHVS's Other Working Capital Changes at -$1.4 million in Q1 2026, $234668.8 in Q4 2025, and $2.3 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Pharvaris	2.17 Bn	1.88 Bn	-

Download Data